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Abstract
Background: Scabies and skin infections are endemic in many Australian Aboriginal communities. There is limited evidence
for effective models of scabies treatment in high prevalence settings. We aimed to assess the level of treatment uptake
amongst clinically diagnosed scabies cases and amongst their household contacts. In addition, we aimed to determine the
likelihood of scabies acquisition within these households over the 4 weeks following treatment provision.
Methods and Findings: We conducted an observational study of households in two scabies-endemic Aboriginal communities
in northern Australia in which a community-based skin health program was operating. Permethrin treatment was provided for
all householders upon identification of scabies within a household during home visit. Households were visited the following
day to assess treatment uptake and at 2 and 4 weeks to assess scabies acquisition among susceptible individuals. All 40
households in which a child with scabies was identified agreed to participate in the study. Very low levels of treatment uptake
were reported among household contacts of these children (193/440, 44%). Household contacts who themselves had scabies
were more likely to use the treatment than those contacts who did not have scabies (OR 2.4, 95%CI 1.1, 5.4), whilst males (OR
0.6,95%CI0.42,0.95)andindividualsfromhigh-scabies-burden households(OR0.2,95%CI0.08,0.77)werelesslikely tousethe
treatment. Among 185 susceptible individuals, there were 17 confirmed or probable new diagnoses of scabies recorded in the
subsequent 4 weeks (9.2%). The odds of remaining scabies-free was almost 6 times greater among individuals belonging to a
household where all people reported treatment uptake (OR 5.9, 95%CI 1.3, 27.2, p=0.02).
Conclusion: There is an urgent need for a more practical and feasible treatment for community management of endemic
scabies. The effectiveness and sustainability of the current scabies program was compromised by poor treatment uptake by
household contacts of infested children and high ongoing disease transmission.
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Introduction
Skin infections are a significant cause of morbidity in
disadvantaged settings around the world [1,2]. Scabies and
pyoderma are endemic in many Aboriginal communities in
northern Australia. These conditions cause local morbidity and
contribute substantially to clinic workload and costs [3].
Moreover, the primary bacterial pathogen underlying most
pyoderma in these communities is Group A Streptococcus (GAS),
which can cause a myriad of debilitating secondary complications
[4], including acute nephritis. Recent evidence also suggests a link
between GAS skin infection and rheumatic fever, and conse-
quently rheumatic heart disease [5]. Post-streptococcal disease
rates in Aboriginal Australians are among the highest in the world
[6]. Scabies is thought to underlie the majority of bacterial skin
infections in these communities [7], thus controlling scabies is
critical to improving skin health and reducing the burden of GAS
secondary complications. Scabies is a disease that often accompa-
nies poverty, with high prevalence being consistently associated
with crowded living conditions [8–10].
Previous experience suggests community-based mass-treatment
approaches are likely to be the most effective for control of scabies
and skin sores in remote Aboriginal communities [1,11–13].
Similar models are used to control endemic parasitic and other
diseases around the world [14–16].
Substantial reductions in the prevalence of scabies in endemic
settings have previously been described with mass community
treatment using oral ivermectin[17] and topical permethrin [18,19].
However, sustainability has been difficult to achieve [2,12],
particularly where there is high mobility between communities
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the success of community-based programs such as this. To maximise
treatment uptake during both mass distribution and routine
screening, the treatment must be acceptable and feasible in the
setting to which it will be applied [20].
A skin health program incorporating mass annual distribution of
permethrin cream, routine scabies screening and treatment at the
clinic and in homes, has been operating in the remote Aboriginal
communities of the East Arnhem region of the Northern Territory
since 2004. Over this time, scabies prevalence amongst children in
the region remained unchanged at 13% [21].
Due to the ongoing scabies burden in these communities we
aimed to assess levels of treatment uptake among households in
which one or more members was seen with scabies during routine
screening. We also sought to investigate acquisition of scabies
among household members during the month after the initial visit.
Methods
Setting and population
The study was conducted in two Aboriginal communities
participating in the East Arnhem Regional Healthy Skin Program
in remote northern Australia. A review of presentations to the
community health clinics in 2006 revealed that 63% of infants had
been diagnosed with scabies and 69% with skin sores in the first
year of life [3].
East Arnhem Healthy Skin Program
The skin program included annual mass community treatment
for scabies (a designated ‘‘Healthy Skin Day’’), combined with
ongoing screening, treatment and follow-up of children aged ,15
years in each community. On Healthy Skin Day, all individuals
were encouraged to apply topical permethrin 5% (Lyclear), which
was distributed directly to all households in the community.
Residents were advised to apply the cream all over the body and
leave it on overnight or for a period of at least 8 hours. Healthy
Skin Day was held within the month prior to the commencement
of data collection for this study.
The East Arnhem program included routine skin assessments of
children under 15 years throughout the year, which aimed to
identify and treat reinfestation arising after the mass community
treatment. These were conducted at the community clinic, during
school screening programs and on home visits. Where a child with
scabies was identified, permethrin cream was provided for all
household members. Locally-relevant resources were produced
and used by local workers to teach people about scabies and skin
health during the assessments. The program team included
doctors, nurses, dermatologists, Aboriginal health workers and
locally employed community workers. A Darwin-based team
visited regularly to support the local community workers. The
program had been operating in these communities for 2.5 years
when this nested study commenced.
The nested study population was households where one or more
children had been diagnosed with scabies during routine home
visits. Data were collected between December 2006 and June
2007. Informed written consent was given by all participating
households. This study was approved by the Human Research
Ethics Committee of the Northern Territory Department of
Health and Menzies School of Health Research (Approval
number 04/11).
Study procedures
A member of the Darwin-based team visited each community
every two weeks during the 6-month study period to assist the
community workers in recruitment and follow-up of households.
Children with scabies were identified during home visits for
routine skin screening undertaken as part of the existing skin
health program (Day 0). The first child from a given household
seen with scabies became the index child for that household. In
line with normal skin program practice, the mother/carer of this
child was provided with permethrin cream for all household
members, together with standardised verbal instructions for cream
use. Local guidelines for scabies treatment indicate that all
household members should be treated, regardless of individual
scabies status. Household members included the index case and all
individuals considered by the index child’s mother/carer to be
living in the house at that time, as occurs during normal skin
health program procedures. All household members other than
the index case are referred to as the index cases’ household
contacts. Instructions were given for the index child and all other
household members to use the cream that night. As noted,
provision of treatment was according to normal skin health
program procedures, and was not dependent on participation in
this study.
The date of birth, sex, scabies and skin sore status of each
household member was recorded. Household members with skin
sores were referred to the clinic for treatment.
Recommendations regarding environmental measures to erad-
icate scabies from the household were also provided, which
included washing all clothing and linen. Participation in these
activities was not necessary for an individual or household to be
considered to have participated fully in treatment. Evidence
indicates that the role of fomites in transmission of scabies is
minimal [22,23]. However we consider these environmental
recommendations to be positive public health messages, particu-
larly in a highly overcrowded setting such as this.
On Day 1 we revisited the home and asked the mother/carer
which household members had used the treatment. Treatment
uptake was defined at the individual and household level. For an
Author Summary
Like many impoverished areas around the world, Aborig-
inal communities in Australia experience an unacceptably
high burden of scabies, skin infections, and secondary
complications. Young children are most at risk. Our study
investigated scabies in a remote setting with very high
rates of skin disease, a high level of household overcrowd-
ing, and limited infrastructure for sanitation and preven-
tive health measures. We assessed uptake of scabies
treatment and scabies acquisition following provision of
treatment by a community-based skin program. In a
household where scabies was present, we found that
treatment with topical permethrin cream of all close
contacts can significantly reduce a susceptible individual’s
risk of infection. Our findings also demonstrate the
challenges of achieving a high level of treatment
participation, with limited permethrin use observed
among household contacts. This suggests an urgent need
for a more practical treatment option. International efforts
to reduce childhood morbidity and mortality have
demonstrated the efficacy of numerous child health
interventions but have also highlighted the deficits in
their delivery and implementation. Experiences like this,
where the effectiveness of a coordinated local program
delivering an efficacious intervention is hampered by poor
treatment uptake and ongoing transmission, are an
important and timely message for researchers, program
managers, and policy-makers.
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primary carer that the household member had used the cream.
Complete household treatment uptake occurred if all household
members were reported to have met the definition for individual
treatment uptake. If household treatment participation was
incomplete, the mother/carer was asked if she could say why
household members had not used the cream.
Subsequent home visits were undertaken on Days 14 and 28 to
screen household members for scabies and skin sores. Additional
permethrin cream was provided as required at these visits.
Utilisation of cream provided after Day 1 was not assessed.
Diagnosis of scabies and skin sores
Scabies was diagnosed clinically by specifically-trained staff,
using accepted criteria and based on the nature and distribution of
characteristic scabies lesions [24,25]. This is the standard and
widely accepted approach to scabies diagnosis in an endemic
setting such as this [17,26,27]. Skin sores were also diagnosed
clinically, based on the presence of any crusted, purulent or dry
sores. Where a household member was not present during the
home visit, we asked the primary carer in the household to report
whether the individual had scabies and/or sores. Findings are
described according to whether a trained Healthy Skin Worker
(HSW) screened the individual or if skin status relied on family
member report.
When measuring scabies acquisition (defined as an individual
who was scabies-free at Day 0 and had a clinical diagnosis of scabies
within 28 days) we classified incident cases as either confirmed or
probable.‘‘Confirmed’’scabiesacquisitionrequiredanindividualto
be seen by a HSW both at baseline (with a clinical diagnosis as
scabies-free) and again at a follow-up (clinical diagnosis of scabies)
Report of scabies acquisition by a family member was considered
‘‘probable’’. These were individuals who were: a) clinically
diagnosed as scabies-free at baseline by a HSW and then reported
to have scabies by a family member at the follow-up visit or; b) were
not seen by a HSW at baseline but were reported to be scabies-free
by a family member and were subsequently diagnosed as scabies by
a HSW at follow-up or were reported to have scabies by a family
member at the follow-up visit.
Analyses
Data were analysed using Intercooled Stata 9 (Stata Corpora-
tion, College Station, Texas, USA). Comparisons of continuous
variables across two levels of a binary variable were conducted
using the Mann Whitney U test. For comparison of proportions
between two binary variables, relative risks and 95% confidence
intervals (CI) were calculated. Chi square test or Fisher’s Exact test
were used to test the significance of associations where
appropriate.
To assess the relative contribution of independent (explanatory)
variables to individual treatment uptake, logistic regression
analysis was implemented using the method of marginal models
estimated using Generalised Estimating Equations (GEE) with
information sandwich estimates of variance. GEE was used due to
the potential for clustering among households. An exchangeable
correlational structure was used. These analyses were performed in
Stata using the xtgee command.
In exploring differences between susceptibles who did and did
not acquire scabies over the one-month follow-up period, GEE
was also employed given the potential for clustering by household.
Since subgroups contained small numbers of individuals, there was
insufficient power to test all explanatory variables by multivariate
GEE model. Therefore, simple (univariate) GEE was performed
for each independent variable of interest. This provided a measure
of the significance of the association between acquiring scabies and
each independent variable while controlling for the potential
influence of household clustering.
Results
Description of sample
Forty households participated, involving 596 individuals (40
index children, 556 household contacts). Median household size
was 15.5 persons (IQR 12, 20). At baseline (Day 0), a median of
23.6% (IQR 11.0, 44.7) of individuals in each household had
scabies as determined by either HSW screening or family member
report (Table 1). All households in which a child with scabies was
identified during normal skin program activities agreed to
participate in the study.
Treatment uptake
Index children. Of the 40 index children, 32 (80%) were
reported to have used the cream. A similar level of treatment
uptake among these children was reported in both communities
(RR 1.3, 95%CI 0.91, 1.72) (Figure 1).
Household contacts. Treatment uptake was established for
440 of the 556 household contacts (79%). Most contacts (247/440,
56%) did not use the cream. Household contacts in Community B
were over 6 times more likely to report treatment uptake than
those in Community A (RR 6.5, 95%CI 3.9, 10.9) (Figure 1).
Complete household treatment uptake. Overall,
household treatment uptake information was available for 37 of
the 40 households. Most households (28/37, 76%) did not have
complete treatment uptake amongst all household members. In
almost 20% of households there was no treatment uptake by any
individual (Figure 2).
In Community B, complete treatment uptake amongst members
was reported by 8 of 21 households (38%). In contrast, there was
only one household in Community A (1/16, 6%) where complete
treatment uptake was reported for all household members.
Although not statistically significant, the point estimate for
complete treatment uptake was 6 times higher in Community B
than Community A (RR 6.1, 95%CI 0.85, 43.9). Similarly, there
was a higher proportion of households with no treatment uptake
reported for any household member in Community A, 31% (5/
16), compared to Community B, 9.5% (2/21) (Figure 2).
Barriers to treatment uptake were reported by the mother/carer
in 24 of the 28 households with either incomplete or no treatment
use. These barriers included the treatment not being a priority
(n=15, 54%), that individuals without scabies felt they did not
need to use the cream (n=11, 46%) and that individuals didn’t
want to use the cream as it was uncomfortable, hot and sticky
(n=10, 42%).
Factors associated with treatment uptake. Households
reporting complete treatment uptake had a significantly lower
median household scabies burden at initial assessment (proportion
of household members with scabies) than those reporting
incomplete treatment uptake: 11% vs. 26%, Z=1.97, p=0.04.
In contrast, household crowding (persons per bedroom) was
similar among households reporting incomplete or complete
treatment uptake (4.0 vs. 3.5 persons per bedroom, respectively)
(Z=0.67, p=0.50).
The odds of treatment uptake was 2.4 times greater among
household contacts with scabies compared to those without (OR
2.4, 95%CI 1.1, 5.4) (Table 2). By contrast, the odds of treatment
uptake was significantly less among males (OR 0.6, 95% CI 0.42,
0.95), individuals from households with a high scabies burden (OR
0.2, 95% CI 0.08, 0.77), and individuals from Community A (OR
Community Management of Endemic Scabies
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95% CI 0.99, 1.01) or household crowding (OR 1.2, 95% CI 0.4,
4.0) influenced treatment uptake.
Acquisition of scabies
Household contacts at risk of scabies. In total, there were
349 individual household contacts who did not have scabies at
baseline (Day 0). Of these, 164 were lost to follow up. Among the
remaining 185 susceptible individuals, there were 9 confirmed
incident cases of scabies and 8 probable incident cases over the 4-
week follow-up period. Including both confirmed and probable
cases, the acquisition rate was 9.2% (17/185). This was 5 times
greater (RR 5.2, 95%CI 2.2, 12.2) in Community A (32%, 7/22)
than Community B (6%, 10/163).
Remaining scabies-free. Among the individuals who did
not have scabies at baseline, remaining scabies-free was not
associated with individual treatment use (OR 1.3, 95%CI 0.4, 3.9,
p=0.6); however the odds of remaining scabies-free was almost 6
times greater among individuals belonging to a household where
all people reported treatment uptake (OR 5.9, 95%CI 1.3, 27.2,
p=0.02). Those who acquired scabies were significantly younger
(median 4.8 years, IQR 2.3,7.4) than those who did not acquire
scabies (median 25.8 years, IQR 11.9,38.7) (Z=4.8, p,0.0001).
There was no evidence that household crowding (OR 1.0, 95%CI
0.6, 1.7, p=0.09) or household scabies burden (OR 1.0, 95%CI
0.9, 1.0, p=0.7) were associated with likelihood of acquiring
scabies among these individuals.
The GEE analyses of confirmed and probable incident cases
provides adjustment for potential clustering by household. Whilst
small numbers preclude a similar analysis amongst the confirmed
cases alone, we have undertaken a secondary analysis (without
controlling for household clustering) to compare the risk factors for
the ‘‘confirmed’’ scabies cases against those household contacts
who did not acquire scabies. Here, consistent with the findings
from the GEE analysis, we found those with ‘‘confirmed’’ scabies
acquisition were more likely to come from a household that did
not have complete treatment uptake and were much younger than
those household contacts who did not acquire scabies (Table 3).
A comparison of susceptible individuals lost to follow up
(n=164) and those for whom scabies status over the 4-week period
was obtained (n=185) revealed two significant differences between
these groups. Individuals were significantly more likely to be
followed-up if they belonged to households with complete
treatment uptake (43.1% vs. 14.9%, RR 1.75, 95%CI 1.5,2.1),
and if they were reported to have used the treatment themselves
(62.2% vs. 39.6%, RR 1.5, 95%CI 1.2, 1.9).
Discussion
Our study is the first to investigate levels and determinants of
treatment uptake in a scabies endemic setting. Treatment uptake
among index children was over 70%, suggesting that it is possible
to achieve high levels of individual treatment use. However,
treatment uptake among the household contacts of these children
was poor and there were very few households in which all
members were reported to have used the treatment. We are likely
to have achieved a higher level of uptake in this study sample than
would otherwise have occurred, given that householders were
aware we would return the following day. Routine Healthy Skin
program procedures do not include this home visit the day after
treatment provision. In addition, self-reported treatment uptake is
likely to be subject to reporting bias, which may also have resulted
in an overestimation of treatment uptake. Therefore, even under
circumstances of increased motivation to use the treatment and
potential over-reporting of uptake, observed rates of treatment use
were still very poor amongst household contacts. This low
participation in treatment has important implications for the
Table 1. Description of participating households and individuals in each community.
Community A Community B p Total
Households N=18 N=22 N=40
Persons per household^* 14.0 (12, 18) 18.0 (14, 21) ,0.001 15.5 (12, 20)
Crowding^ (persons per bedroom) 4.3 (3.3, 5.3) 4.5 (3.5, 5.3) 0.510 4.3 (3.5, 5.3)
% householders under 5 years^ 14.4 (9.6, 22.0) 20.5 (14.9, 24.7) 0.134 17.9 (12.3, 24.1)
Household scabies burden at Day 0^* (% householders
with scabies)
33.3 (17.1, 50) 16.2 (9.1, 26.3) ,0.001 23.6 (11.0, 44.7)
% householders screened at Day 0^ 47.7 (27.6, 67.2) 44.5 (33.3, 66.3) 0.946 46.4 (31.0, 67.1)
Individuals
Index children N=18 N=22 N=40
Age (years)^ 3.9 (1.1, 10.8) 2.7 (0.7, 5.5) 0.265 3.4 (1.0, 5.9)
Sex (% male) 50% (n=9) 50% (n=11) 1.0 50% (n=20)
Scabies at Day 0
& 100% (n=18) 100% (n=22) 1.0 100% (n=40)
Contacts N=221 N=335 N=556
Age (years)^ 19.0 (7.8, 33.5) 22.0 (6.5, 33.2) 0.973 20.2 (7.4, 33.4)
Sex (% male)
# 50.5% (n=110/218) 51.4% (n=165/321) 0.830 51.0% (n=275/539)
Scabies at Day 0
#*+ 21.7% (n=30/138) 12.7% (n=35/276) 0.017 15.7% (n=65/414)
^Values are median (IQR).
#Individuals with unknown status (missing data) have not been included – denominator for calculation of percent is individuals with known values.
*Significant difference between Community A and Community B (p,0.05), Wilcoxon Rank Sum test for continuous variables, Chi Square for categorical variables.
&All cases diagnosed by Healthy Skin Worker (HSW).
+In Community A, 13 cases diagnosed by HSW, 17 by family report. In Community B, 22 cases diagnosed by HSW, 13 by family report.
doi:10.1371/journal.pntd.0000444.t001
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achieved with the community-based model employed here.
Our findings support current recommendations for universal
treatment of close contacts where scabies is present, with the odds
of scabies acquisition being greatest among young children and
individuals in households with incomplete treatment uptake. Even
in an endemic setting characterised by high mobility between
households, universal treatment among family members in
households where scabies was present significantly reduced the
likelihood of acquisition among susceptible individuals. This is
critical to protect young children, who are most at risk of infection.
However, we have also demonstrated that the current approaches
Figure 2. Percentage of households reporting complete or incomplete treatment uptake among households members in each
community and combined.
doi:10.1371/journal.pntd.0000444.g002
Figure 1. Reported treatment uptake among index children (A) and household contacts (B) in each community and in total.
Denominator used in calculation of percentage includes individuals with unknown status.
doi:10.1371/journal.pntd.0000444.g001
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in this setting. Although there was an established community-
based control program in the two communities in which this study
was conducted, we observed a very high level of secondary
transmission. While the risk of secondary transmission remained
unacceptably high in both communities, it was five times higher in
Community A than Community B. The former had both a
comparatively higher household burden of scabies and lower levels
of treatment uptake amongst household contacts, which helps to
explain the differential.
Overall, reported treatment uptake was poorest in settings with
a high scabies burden. This was observed at both the community
level and at the household level. As noted, Community A had a
higher median household scabies burden compared to Commu-
nity B, and significantly less treatment uptake. In addition,
irrespective of community of residence, an individual from a
household with a high scabies burden was less likely to use the
treatment than an individual from a household with a low scabies
burden. The depressing reality for many households in these
communities may well be that scabies has become part of life. At
the individual level, treatment failure, or failure of others to
adequately treat, creates an ongoing cycle of scabies transmission
within both the household and the community. This may well
contribute to the likelihood that those households with high scabies
burden become increasingly less likely to treat.
A number of community-based initiatives have documented a
sustained reduction in scabies burden in endemic settings using
topical permethrin. In Panama, directly observed permethrin
treatment of all inhabitants of an island community, together with
ongoing surveillance and treatment of new cases, resulted in a
significant reduction in scabies prevalence [18]. Similar results
have previously been reported in Australian Aboriginal commu-
nities without the requirement of directly observed treatment
[12,13]. That the achievements of previous programs have not
been observed here may reflect community-specific factors, such as
social or environmental characteristics, which may not be
generalisable to other communities or regions. Indeed, even in
the current study we identified marked differences in treatment
participation and household scabies burden between the two
participating communities. Furthermore, given the low levels of
treatment participation observed here, it seems unlikely that
complete participation would have been achieved during the mass
community treatment event that took place in the weeks prior to
our study. If a substantial and rapid reduction in community
scabies prevalence could be achieved through complete participa-
tion in mass treatment, the subsequent management of new cases
at the household level may be a more feasible and effective
approach. However, the high level of movement within and
between households and communities would still present signifi-
cant challenges to maintaining a low prevalence of scabies.
The difficulty in achieving a sustained reduction in scabies
burden in these settings has previously been recognised [2,12,18].
In Australia and many other countries, topical preparations such
as permethrin cream are the only approved treatment for
community management of scabies. The practicality of topical
treatment for the community management of endemic scabies has
been questioned [9,25]. Indeed, several characteristics of the
treatment and setting give reason to doubt that a sustained
reduction in scabies prevalence can be achieved with this
approach. Environmental factors make total-body topical treat-
ment impractical. These factors include the large number of
people in each house, high heat and humidity, limited opportu-
nities for privacy to apply the cream [1], and poor infrastructure
for washing it off [28]. When complete treatment uptake does
occur, there is a strong likelihood of rapid reinfestation due to the
high prevalence of scabies, overcrowding and frequent movement
between households and communities. A realistic consequence of
this is low motivation to repeat the treatment process.
The likelihood of individual participation in treatment for the
community management of endemic parasitic infection has been
linked to expected personal benefit and expected personal cost
[29]. It seems likely that the low level of uptake observed here,
particularly where there is a high burden of scabies, is
symptomatic of low motivation to participate in a treatment
Table 3. Comparison of confirmed incident cases and non-cases.
Acquired scabies (N=9) Did not acquire scabies (N=168)
Individual treatment uptake Yes 62.5% (5/8) Yes 63.0% (102/162) RR 1.2, 95%CI 0.33, 4.64
Belongs to household with complete
treatment uptake*
Yes 0% (0/9) Yes 46.1% (76/165) RR, 95%CI – N/A; p=0.005
Age^ (years)* 5.8 (11.3,2.3) 25.8 (38.7,11.9) Z=3.2, p=0.001
Household crowding^ 4.0 (5.3, 3.5) 4.0 (5.3, 3.5) Z=0.09, p=0.930
Household scabies burden 8.3 (26.7, 5.3) 15.8 (25.0, 7.7) Z=1.05, p=0.295
^Median (IQR).
*Significant difference between confirmed incident case and non-case.
Note where there are individuals with unknown status, % has been calculated based on total individuals with known status.
N/A -point estimate and confidence intervals cannot be calculated due to nil value.
doi:10.1371/journal.pntd.0000444.t003
Table 2. Multivariate GEE model of factors associated with
individual treatment uptake among household contacts.
OR 95% CI
Scabies* 2.4 1.10, 5.43
Sores 2.3 0.88, 5.86
Age 1.0 0.99, 1.01
Household crowding 1.2 0.36, 4.04
Sex (male)* 0.6 0.42, 0.95
Community* 0.2 0.05, 0.69
Household scabies burden* 0.2 0.08, 0.77
*Significant association with individual treatment uptake.
OR odds ratio, CI confidence interval.
doi:10.1371/journal.pntd.0000444.t002
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seen to have limited effectiveness (low personal benefit). This is
supported by the reasons cited for non-participation in treatment,
the most common of which was that using the treatment wasn’t a
priority. Many also reported the inconvenience and unpleasant-
ness of the treatment to be a key barrier to use.
Of additional concern is the potential for the development of
drug resistance [30,31] when such long-running community disease
control programs achieve only limited participation and disease
reduction. Concerns regarding mite resistance to permethrin have
recently been described in a number of Aboriginal communities in
northern Australia [32,33]. Thus it is possible that even if greater
levels of treatment participation could be achieved, resistance to this
treatment may undermine any potential impact on disease burden.
These findings demonstrate an urgent need for a more suitable
treatment for scabies to reduce the burden in endemic settings.
Oral ivermectin has demonstrated success in the community
management of endemic scabies [17,26,27]. For example, in the
Solomon Islands, mass ivermectin administration to all residents of
a small number of islands, combined with treatment of any
individuals subsequently entering or returning to the communities,
reduced scabies prevalence from 25% to ,5% after four months,
and was subsequently sustained at ,1% [17].
Ivermectin is also widely used in community control of other
parasitic infestations. Since 1987, it has been used extensively in
community-based mass treatment programs in Africa and Latin
America to control endemic onchocerciasis [34]. The Global
Programme to Eliminate Lymphatic Filariasis recently reported
that between 2000 and 2007, 149 million treatments of ivermectin
had been given through community-based mass drug administra-
tion in 12 African countries [35]. Ivermectin is also effective
against other parasitic infestations that can occur in high-scabies
burden settings, such as strongyloidiasis [26], which is endemic in
many Australian Aboriginal communities [36].
Ivermectin is not currently approved for the mass community
management of scabies in Australia. Notwithstanding, a growing
body of literature indicates it is safe and effective when used in
mass drug treatment programs and is ideally suited for use in the
community as it is a single oral dose that is easily administered. In
2003, it was estimated that 6 million people worldwide had taken
ivermectin for various parasitic infestations with no serious drug-
related adverse events reported [37]. Contributing to the safety
profile is the accumulation of non-event data among pregnant
women [38–40].
While ivermectin presents a viable alternative for the manage-
ment of scabies, especially where compliance with topical
treatment is improbable or impractical [34,37], the provision of
a more practical treatment alone is unlikely to completely resolve
the low treatment participation seen here. Many households cited
reasons for non-participation that may not be readily resolved
simply with a more practical treatment. For example, there is an
enduring perception that individuals without scabies do not need
to be treated. Factors that have been identified as important for
treatment participation and program success in mass ivermectin
administration include strong community education and aware-
ness-raising, engaging well-trained health workers who are trusted
and respected by the community, and community involvement
and ownership in the program [41–43]. It will be critical to
consider such factors in the implementation of any initiative to
reduce the burden of scabies in these communities, and to work
together with communities to better understand household and
individual barriers to program participation.
Our study has several limitations that are inherent to research in
this setting. With large and transient family groups, the concept of
a household unit is tenuous and follow-up of individuals is
compromised. While complicating data collection, this also further
highlights the challenge of infectious disease management at the
household level. In our study, almost half of the susceptible
individuals were lost to follow up. We must therefore consider the
possibility that those individuals who were followed up represent a
biased sample of the population at risk. Those who were lost to
follow up were significantly less likely to belong to a household in
which all members used the treatment, and less likely to use the
treatment themselves. This suggests that we have missed a segment
of the susceptible population that may indeed be at a higher risk of
acquiring scabies, and we may therefore have underestimated
acquisition.
Where a household member was unwilling or unavailable to
participate in skin screening, a family member reported scabies
status for that individual. Ideally, all household members would
have been available for skin screening. The presence of itching and
visible skin lesions in a household where scabies is known to be
present has been reported to be highly specific [11]. Notwith-
standing, here we have distinguished between scabies cases
diagnosed by a trained worker (confirmed case) and those reported
by a family member (probable case) in order to mitigate any
potential impact of this on the validity of our data.
There is limited evidence for the effective, long-term manage-
ment of scabies in high prevalence areas [44]. Achieving a
significant reduction in infectious disease burden in an endemic
setting requires a high level of treatment coverage among those
exposed to the disease. Here we have demonstrated a lower
likelihood of scabies acquisition when all close contacts participate
in treatment. This emphasises the importance of all close contacts
of scabies cases being treated, whether symptomatic or not. This is
recommended in all settings where scabies is present. However,
achieving this high level of participation in treatment can pose a
considerable challenge. Our findings indicate that the long-term
management of scabies with topical permethrin has not been
effective, as evidenced by low rates of treatment uptake and
ongoing transmission. These results support the notion that, in
controlling infectious diseases such as scabies at the community
level, it is critical that the treatment be appropriate, acceptable
and feasible in the setting to which it will be applied. It is also
fundamental to recognise that the eradication of scabies and other
infectious diseases in these settings cannot be achieved by
treatment alone. To realise a significant and sustained reduction
in disease burden requires that the underlying environmental and
social conditions that promote such poor health be addressed.
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